In Brief: Ion Laser Technology
This article was originally published in The Gray Sheet
Ion Laser Technology: Completes documentation to bring all lasers into compliance with issues raised in June 18 FDA warning letter ("The Gray Sheet" July 1, I&W-6). ILT says July 2 that it has made the changes on all new products and has submitted a written plan to bring all previously shipped products into compliance...
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.